Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,355 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,367)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07698106 | Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC | not yet recruiting | Phase 1 / Phase 2 | 60 | University Health Network, TorontoOTHER | 0 | Sep 28, 2026 | clinicaltrials |
| NCT07844018 | ADC Based Therapy Accroding to HER2 Heterogeneous(HER2level) | not yet recruiting | Phase 2 | 88 | Peking University People's HospitalOTHER | 1 | Sep 28, 2026 | clinicaltrials |
| NCT07844291 | A Prospective, Open-label, Randomized Trial Comparing Switch to A1811 Versus Continued THP Neoadjuvant Therapy After THP Induction in HER2-Positive Breast Cancer(SwithADC) | not yet recruiting | N/A | 432 | Peking University People's HospitalOTHER | 0 | Sep 28, 2026 | clinicaltrials |
| NCT07844759 | SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers(SOLIS) | not yet recruiting | N/A | 30 | Renaissance Institute of Precision Oncology and RadiosurgeryOTHER | 1 | Sep 28, 2026 | clinicaltrials |
| NCT07419880 | Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer(RECLAIM) | not yet recruiting | Phase 2 | 46 | Fudan UniversityOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT07840534 | Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU)(LYSA2PIFU) | not yet recruiting | N/A | 30 | University College CorkOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT07840599 | Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients(Fit2ThriveMB) | not yet recruiting | N/A | 224 | Northwestern UniversityOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT07841704 | NAUTILUS-04: No Axillary Surgical Treatment in Low-Risk Clinically Node-Negative Breast Cancer Without Whole-Breast Radiotherapy - A Prospective, Randomized, Phase III, Non-inferiority Clinical Trial(NAUTILUS-04) | not yet recruiting | N/A | 1,520 | Wonshik HanOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT07838649 | Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity | not yet recruiting | Phase 1 | 36 | Washington University School of MedicineOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT07185568 | IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving Surgery for Non-palpable Tumors(MANOLA) | not yet recruiting | N/A | 1,302 | Istituto Oncologico Veneto IRCCSOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT07835698 | The Validation of ICBT Clinical Trial: Disease Stress Adjustment in Breast Cancer Patients(ICBT-TW-2) | not yet recruiting | N/A | 100 | National Health Research Institutes, TaiwanOTHER | 0 | Sep 23, 2026 | clinicaltrials |
| NCT07836257 | A Phase II Study of Trastuzumab Deruxtecan (T-DXd) Plus Pyrotinib in HER2-Positive Advanced Breast Cancer After Progression on T-DXd | not yet recruiting | Phase 2 | 28 | Fujian Medical UniversityOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT07528768 | HEADWATERS: Gemcitabine vs Paclitaxel in Metastatic Triple-Negative Breast Cancer in Women of African Ancestry. | not yet recruiting | Phase 2 | 750 | The University of The West IndiesOTHER | 3 | Sep 22, 2026 | clinicaltrials |
| NCT07619365 | Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer | not yet recruiting | Phase 2 | 60 | Washington University School of MedicineOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT07770243 | AI-Based Symptom Management for Post-Treatment Breast Cancer Survivors(AIMS-BC) | not yet recruiting | N/A | 36 | Hong Kong Metropolitan UniversityOTHER | 0 | Sep 22, 2026 | clinicaltrials |
| NCT07833085 | CAIX-targeted PET/CT in Solid Tumors(CAIX-PET) | not yet recruiting | N/A | 100 | Zhongnan HospitalOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT07833891 | Senocohort: Identification of Predictive Biomarkers in Breast Cancer Treatment(SENOCOHORT) | not yet recruiting | — | 500 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Sep 22, 2026 | clinicaltrials |
| NCT07831889 | Hypofractionated Radiotherapy After Breast Reconstruction for Breast Cancer | not yet recruiting | N/A | 960 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Sep 21, 2026 | clinicaltrials |
| NCT06882499 | Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II(AVATARII) | not yet recruiting | N/A | 74 | Peter MacCallum Cancer Centre, AustraliaOTHER | 0 | Sep 18, 2026 | clinicaltrials |
| NCT07631026 | Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery | not yet recruiting | N/A | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07828054 | Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients With Breast Cancer Treated With Trastuzumab Deruxtecan(MARGARET) | not yet recruiting | Phase 3 | 244 | Mario Negri Institute for Pharmacological ResearchOTHER | 0 | Sep 18, 2026 | clinicaltrials |
| NCT07828652 | Real-world Treatment Outcomes and Safety of Neoadjuvant Pembrolizumab-containing Therapy in Patients With Triple-negative Breast Cancer: Korean Nationwide Multicenter Study (Pembro-Real World) | not yet recruiting | — | 2,000 | Yeon Hee ParkOTHER | 0 | Sep 18, 2026 | clinicaltrials |
| NCT07825454 | Pilot Study of Hydroxychloroquine for the Treatment of AIMSS(AIMSS) | not yet recruiting | Phase 2 | 35 | Indiana UniversityOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07826052 | Chemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- Breast Cancer(ELDER) | not yet recruiting | Phase 2 | 494 | Fudan UniversityOTHER | 0 | Sep 17, 2026 | clinicaltrials |
| NCT07748208 | A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes | not yet recruiting | Phase 2 | 40 | Hoffmann-La RocheINDUSTRY | 0 | Sep 16, 2026 | clinicaltrials |
| NCT07638150 | PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)(PRIME) | not yet recruiting | N/A | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07743723 | A Study of IOV-5001 in Adults With Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 106 | Iovance Biotherapeutics, Inc.INDUSTRY | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07819981 | Prehabilitation for Improving Outcomes in Breast Cancer Patients Undergoing Neoadjuvant Systemic Treatment and Surgery | not yet recruiting | N/A | 20 | City of Hope Medical CenterOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07651267 | Financial Toxicity, Quality of Life, and Psychological Resources in Breast Cancer Survivors : A Longitudinal Study(FTQoL-BC) | not yet recruiting | — | 160 | Okayama UniversityOTHER | 0 | Sep 11, 2026 | clinicaltrials |
| NCT07374796 | Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer | not yet recruiting | — | 450 | University of Maryland, BaltimoreOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT07776964 | Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) | not yet recruiting | N/A | 72 | University of MinnesotaOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT07501637 | Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors | not yet recruiting | N/A | 30 | University of Alabama at BirminghamOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT07781800 | Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health | not yet recruiting | N/A | 180 | Washington University School of MedicineOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT07806084 | Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF(Bone Pain) | not yet recruiting | — | 132 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Sep 8, 2026 | clinicaltrials |
| NCT07807345 | Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic | not yet recruiting | Phase 1 | 285 | Sutro Biopharma, Inc.INDUSTRY | 1 | Sep 8, 2026 | clinicaltrials |
| NCT07300475 | Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients | not yet recruiting | Phase 1 | 30 | Washington University School of MedicineOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT07801898 | Neoadjuvant Endocrine Therapy Combined With Chemotherapy in ER-positive, HER2-negative Stage I-III Breast Cancer | not yet recruiting | Phase 2 | 36 | The Second Hospital of Anhui Medical UniversityOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT07802847 | Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.(POG) | not yet recruiting | Phase 4 | 794 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT07799337 | IRELAND Trial: A Translational Biomarker and Exercise Study During Neoadjuvant Breast Cancer Therapy(IRELAND) | not yet recruiting | N/A | 250 | National University of Ireland, Galway, IrelandOTHER | 0 | Sep 2, 2026 | clinicaltrials |
| NCT07799467 | Implementing a Digital Alcohol Intervention to Raise Women's Awareness of Alcohol-related Breast Cancer Risk During Routine Screening Visits | not yet recruiting | N/A | 36 | University of MiamiOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07789912 | BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies(BRAVO-LM) | not yet recruiting | Phase 2 | 40 | University of MiamiOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07795424 | Culmerciclib Combined With Letrozole and Dual HER2 Blockade as Neoadjuvant Therapy for HR+/HER2+ Breast Cancer | not yet recruiting | Phase 2 | 33 | Shengjing HospitalOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT06926530 | Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations | not yet recruiting | — | 240 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07725172 | Radiation Therapy and Thymus Function in Young Women With Breast Cancer | not yet recruiting | — | 125 | Duke UniversityOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07768358 | Tucatinib Continuation Study | not yet recruiting | Phase 4 | 175 | PfizerINDUSTRY | 0 | Aug 28, 2026 | clinicaltrials |
| NCT07781852 | Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer | not yet recruiting | Early Phase 1 | 40 | Lumina Pharmaceuticals IncINDUSTRY | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07791771 | SLNB Combined With WLNB for Axillary De-escalation in Breast Cancer Patients With Abnormal Axillary Nodes | not yet recruiting | — | 84 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07793721 | Effects of Risk Presentation Format and Frequently Asked Questions on Breast Cancer Risk Skepticism | not yet recruiting | N/A | 3,000 | University of Colorado, DenverOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07782814 | An Investigation Into Dielectric Testing for the Evaluation and Characterisation of Breast Tissue Using a Novel Time-Domain Bioimpedance Tool(DiTECT) | not yet recruiting | — | 220 | Zedsen LimitedINDUSTRY | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07791368 | Developing and Testing the Efficacy of AI-Chatbot-Based | not yet recruiting | N/A | 68 | National Taiwan University HospitalOTHER | 1 | Aug 27, 2026 | clinicaltrials |
Data updated 22 hours agoSource updated Sep 28, 2026source: clinicaltrials